Heart Blocks Treatment Devices Market Report
Heart Blocks Treatment Devices Market, By Type (First-Degree Heart Block, Second-Degree Heart Block, Third-Degree Heart Block), By Product (Transcutaneous Pacing, Pacemaker, Mediation, Follow-up Electrophysiology Study), By End User (Hospital Testing, Home treatment, Clinics, Others) and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global heart blocks treatment devices market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
Heart Blocks Treatment Devices Market, By Type (First-Degree Heart Block, Second-Degree Heart Block, Third-Degree Heart Block), By Product (Transcutaneous Pacing, Pacemaker, Mediation, Follow-up Electrophysiology Study), By End User (Hospital Testing, Home treatment, Clinics, Others) and Region ...
Impact of COVID-19 on Heart Blocks Treatment Devices Market
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Heart Blocks Treatment Devices Market is estimated to grow from USD 2.8 billion in 2020 to USD 3.8 billion by 2026 at a healthy CAGR of 5.4% during the forecast period.
Heart blocks are also referred to as atrioventricular (AV) blocks which is a condition, in which the electric signals that control the heartbeat are fairly or completely blocked from reaching the ventricles. Different devices that can be used to treat heart blocks comprise a pacemaker that uses electric signals to normalize heartbeat at a standard rate.
Key players operating in the heart blocks treatment devices market are-
The rapidly growing incidence of cardiovascular disease is one of the major factors intensifying the growth and demand of heart blocks treatment devices market in the coming years. Moreover, the increasing number of geriatric inhabitants around the world is also influencing the market growth. Also, the development of pacemakers and minimally invasive cardiovascular treatment coupled with the rapidly changing standard of living are also improving the growth of the market growth during the forecast period.
Based on Product, the market has been classified into transcutaneous pacing, pacemaker, mediation, and follow-up electrophysiology study. The pacemaker segment accounted for a substantial market share in 2020. Growing incidences of Cardiovascular Diseases (CVDs), increasing cost of cardiac disease management, favorable government policies, and the emergence of technologically advanced pacemakers such as leadless pacemakers and MRI safe pacemakers, further bolster the segment growth.
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure, increasing investment in R&D activities, higher adoption of these technologies, and favorable government initiatives. Moreover, the favorable reimbursement policies, high rate of R&D activities, easy availability of advanced technology, and enhanced patient knowledge within the region, further proliferates the regional growth.
The COVID-19 outbreak positively influenced the growth of the heart blocks treatment devices market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. Rise in heart patients and cardiovascular diseases and as they are highly prone to get infected by COVID-19, there is strong growth of heart blocks treatment devices during the pandemic.
Here is the list of the group of customers that the heart blocks treatment devices market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at email@example.com.
The heart blocks treatment devices market is expected to witness an impressive growth of 5.4% CAGR in the coming years.
Medtronic (US), Abbott (US), MicroPort Scientific Corporation (China), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (US), LivaNova PLC (UK), Lepu Medical Technology (Beijing) Co., Ltd. (China), McKesson Corporation, Stryker, and SCHILLER (Switzerland) are among the key players in the heart blocks treatment devices market.
The heart blocks treatment devices market size is expected to reach USD 3.8 billion in the foreseeable future.
The pacemaker segment accounted for the substantial share in the heart blocks treatment market in 2020.
North America is expected to remain dominant in the heart blocks treatment market in the next five years.
Heart Blocks Treatment Devices distributors, Heart Blocks Treatment Devices suppliers, Heart Blocks Treatment Devices manufacturers, Hospitals, Government bodies are the target audience in the heart block treatment market.